Chronic Pulmonary Aspergillosis may have lethal impact among People with Lung Conditions, Says AIIMS Study Medical Dialogues Team13 Jan 2025 8:15 PM ISTNew Delhi: A study by researchers at the All India Institute of Medical Sciences (AIIMS) in New Delhi has revealed the alarming threat posed by...
12-months oral itraconazole most optimal for prevention of relapse of chronic pulmonary aspergillosis: Lancet Medha Baranwal15 April 2022 7:30 PM ISTChandigarh, India: 12 months of treatment with oral itraconazole in patients with chronic pulmonary aspergillosis is superior to 6 months of oral...
